AML with Mutations in IDH1 and DNMT3A Exhibits a Distinct Epigenetic Signature with Poorer Overall Survival

被引：2

作者：

Ahr, Katya ^{[1
]}

Famulare, Christopher ^{[2
]}

Koche, Richard ^{[3
]}

Spitzer, Barbara ^{[4
]}

Levine, Ross L. ^{[5
]}

Tallman, Martin S. ^{[2
]}

Goldberg, Aaron D. ^{[2
]}

Stein, Eytan M. ^{[6
]}

Glass, Jacob L. ^{[2
]}

机构：

[1] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pediat, BMT Serv, 1275 York Ave, New York, NY 10021 USA

[5] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, 1275 York Ave, New York, NY 10021 USA

[6] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Div Hematol Oncol, 1275 York Ave, New York, NY 10021 USA

来源：

关键词：

D O I：

10.1182/blood-2018-99-118407

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1471

引用

页数：4